Enterprise Financial Services Corp (EFSC)’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-27
Closed -$5K – 1174
2021
Q2
$5K Hold
27
– – ﹤0.01% 941
2021
Q1
$5K Hold
27
– – ﹤0.01% 951
2020
Q4
$4K Hold
27
– – ﹤0.01% 959
2020
Q3
$3K Sell
27
-7
-21% -$768 ﹤0.01% 1001
2020
Q2
$4K Buy
34
+24
+240% +$2.7K ﹤0.01% 924
2020
Q1
$1K Buy
+10
New +$950 ﹤0.01% 1227
2017
Q2
– Sell
-94
Closed -$13K – 1054
2017
Q1
$13K Hold
94
– – 0.01% 564
2016
Q4
$13K Buy
94
+47
+100% +$6K 0.01% 551
2016
Q3
$6K Buy
+47
New +$5.65K ﹤0.01% 705
2016
Q1
– Sell
-23
Closed -$4K – 1138
2015
Q4
$4K Buy
+23
New +$3.35K ﹤0.01% 789
2015
Q2
– Sell
-20
Closed -$3K – 1214
2015
Q1
$3K Hold
20
– – ﹤0.01% 937
2014
Q4
$3K Hold
20
– – ﹤0.01% 950
2014
Q3
$3K Sell
20
-13
-39% -$1.34K ﹤0.01% 938
2014
Q2
$3K Hold
33
– – ﹤0.01% 971
2014
Q1
$3K Hold
33
– – ﹤0.01% 973
2013
Q4
$4K Hold
33
– – ﹤0.01% 843
2013
Q3
$3K Hold
33
– – ﹤0.01% 919
2013
Q2
$2K Buy
+33
New +$2.13K ﹤0.01% 870

Other funds holding UTHR

Enterprise Financial Services Corp (EFSC)'s UTHR Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of United Therapeutics (UTHR) in Q3 2021, closing a stake of 27 shares — an estimated $5K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in UTHR in Q2 2013 and held it in 18 quarters. The position peaked at $13K in Q1 2017. 426 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining United Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 27 United Therapeutics shares in Q3 2021, an estimated $5K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in United Therapeutics in Q2 2013 and held it in 18 quarters.
  • Enterprise Financial Services Corp (EFSC)'s United Therapeutics position peaked at $13K in Q1 2017.
  • 426 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.